BSE: ZYDUSLIFE - Zydus Lifesciences Limited

六个月盈利: -8.83%
部门: Healthcare

促销时间表 Zydus Lifesciences Limited


关于公司

Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, Europe, Latin America, the Asia Pacific, and Africa. The company operates in Pharmaceuticals and Consumer Products segments.

更多详情
It offers finished dosage human formulations comprising generics, branded generics, and specialty formulations, including biosimilars and vaccines; active pharmaceutical ingredients; consumer wellness products; and products in the therapeutic areas of pain management, neurology, dermatology, liver diseases, and other areas. The company also provides consumer wellness products, such as Complan; EverYuth, a range of skincare products; Nycil; Glucon-D glucose powder; Nutralite; Nutralite Doodhshakti, a portfolio of dairy products; and various other products. In addition, the company offers a pipeline of biological products in the areas of oncology, autoimmune disease, nephrology, ophthalmology, inflammation, rheumatology, hepatology, infectious disease, etc. Further, it engages in the investment, animal health and veterinary, pharmacy retail, and manpower supply and administration activities. The company was formerly known as Cadila Healthcare Limited and changed its name to Zydus Lifesciences Limited in February 2022. Zydus Lifesciences Limited was founded in 1952 and is based in Ahmedabad, India.

EBITDA 25.16
EV/EBITDA 14.03
ISIN INE010B01027
Industry Pharmaceuticals
P/BV 2.4
P/E 23.93
P/S 2.04
Sector Health Care
Валюта inr
Валюта отчета inr
Выручка 138.12
Див.доход ао 1.34
Дивиденд ао 6
Сайт https://zyduslife.com
Цена ао 1054.35
Число акций ао 1.0122 млрд
每日价格变化: +1.37% (959.55)
每周价格变化: -0.1232% (973.9)
每月价格变化: +2.31% (950.7)
3个月内价格变化: -9.48% (1074.6)
六个月内的价格变化: -8.83% (1066.95)
每年价格变化: +41.75% (686.2)
3年内价格变化: +119.03% (444.1)
5年内价格变化: +332.98% (224.65)
10年价格变化: 0% (972.7)
年初以来价格变化: -1.55% (988)

低估

姓名 意义 年级
P/S 5.29 2
P/BV 4.55 3
P/E 26.06 6
EV/EBITDA 14.65 7
全部的: 5

效率

姓名 意义 年级
ROA, % 14.03 4
ROE, % 20.67 7
全部的: 4.17

股息

姓名 意义 年级
Div yield, % 0.7249 1.8
DSI 0.8571 8.57
全部的: 2.58

责任

姓名 意义 年级
Debt/EBITDA 0 10
全部的: 10

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 37.72 5
盈利能力 Ebitda, % 36.84 5
盈利能力 EPS, % 233.73 10
全部的: 7.2



导师 职称 支付 出生年份
Dr. Sharvil Pankajbhai Patel MD & Executive Director 262.5M 1979 (46 年)
Dr. Ganesh Narayan Nayak COO & Executive Director 120M 1955 (70 年)
Mr. Punit Patel President & CEO of America N/A
Mr. Nitinkumar Dalsukhray Parekh Chief Financial Officer 54.31M
Mr. Arvind Bothra Head of Investor Relations N/A
Mr. Dhaval Narendra Soni Company Secretary & Compliance Officer 2.09M

地址: India, Ahmedabad, Zydus Corporate Park - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://zyduslife.com